Background: Surgical-site infections (SSIs) increase patient morbidity and costs. The aim was to identify and synthesize all RCTs evaluating the effect of topical antibiotics on SSI in wounds healing by primary intention. Conclusion: Topical antibiotics probably prevent SSI compared with no topical antibiotic or antiseptic. No conclusion can be drawn regarding whether they cause allergic contact dermatitis.
Introduction
Many surgical procedures are performed every year; the majority result in wounds that heal by primary intention. Surgical-site infections (SSIs) account for up to 20 per cent of all of healthcare-associated infections 1 . At least 5 per cent of patients who have a surgical procedure will develop an SSI 2 . SSIs can delay healing, impair cosmetic outcomes and potentially cause other morbidity, such as deeper infections, as well as increase costs and the consumption of healthcare resources 3 .
The acceptable rate of SSI following clean surgery (class 1) is less than 5 per cent 4, 5 , although some patients and procedures are at higher risk. Therefore, oral antibiotic prophylaxis of clean surgical wounds is usually reserved for at-risk patients or high-risk procedures 3, 6, 7 . Although limited guidelines exist for the use of oral antibiotics as infection prophylaxis, there is no guidance on the prophylactic use of topical antibiotics.
The only information available on the frequency of topical antibiotic use on wounds is a survey of plastic surgeons in the UK, which revealed that 66 per cent used chloramphenicol eye ointment in their practice 8, 9 .
Adverse effects include allergic contact dermatitis, anaphylaxis and antibiotic resistance 10 -12 . There is little evidence in the literature regarding the efficacy of antibiotic ointment in preventing SSI, and some existing evidence is conflicting. A systematic review of trials is important to guide clinical practice. The authors conducted a Cochrane Review 13 , which is summarized in this article. Better information on efficacy could assist in rationalizing use and contribute to controlling development of antibiotic resistance in the community. The primary aim of this review was to determine whether the application of topical antibiotics after primary closure reduces the incidence of SSI.
Methods

Criteria for considering studies for this review
All RCTs or quasi-randomized trials examining surgical wounds healing by primary intention were included. There was no limitation for age, sex, country of origin or surgical setting. Secondarily infected wounds, wounds healing by secondary intention and the application of prophylaxis before closure were excluded. Ointments, creams, lotions, solutions, gels, tinctures, foams, pastes, powders and impregnated dressings were included in the definition of topical antibiotic, but not silver or antiseptics. Excluded were antibiotic irrigation or washouts, subcutaneous infiltration of the antibiotic, any topical treatment applied before closure by primary intention and antibiotic-coated sutures. The topical antibiotic may have been applied with, or without a dressing. The comparison group was topical antiseptic or no treatment.
The primary outcome was SSI, as defined by the US Centers for Disease Control and Prevention. In this definition, infection must occur within 30 days of the procedure, so this time point was used as a cut-off for this primary outcome measure. The trial authors' definitions of infection were accepted. Adverse effects within 30 days of the procedure were also a primary outcome, and were defined as allergic contact dermatitis, anaphylaxis or infections with patterns of antibiotic resistance.
Literature search
The following electronic databases were searched to identify reports of relevant RCTs from inception to Clinical trials registries and bibliographies of all retrieved and relevant publications identified were searched for additional eligible trials, and manufacturers and pharmaceutical companies contacted regarding studies for inclusion.
Data extraction
Two review authors screened the titles and abstracts independently. They obtained a copy of the full article for potentially eligible studies. Any discrepancies were resolved by consensus discussion with a third author. Where necessary and possible, additional information was sought from the principal investigator of the trial concerned.
The following data were extracted: eligibility criteria, trial characteristics, methods, participants, intervention, control group, outcome definitions and outcome data for primary and secondary outcomes, and key conclusions of study authors.
Assessment of risk of bias in included studies
Two review authors independently assessed each included study for risk of bias (selection bias, performance bias and attrition bias) 16 . A threshold was set such that trials assessed as at risk of either random number generation, allocation concealment or assessor blinding were considered to be at high risk of bias. If missing outcome data were distributed unequally over the intervention arms, the study was deemed to be at high risk of attrition bias, and the authors considered performing an intention-to-treat analysis.
Statistical analysis
All outcomes measured in the review were dichotomous. Risk ratio (RR) was used as the effect measure, with 95 per cent c.i. I 2 was interpreted according to the Cochrane Handbook 14 , taking into account factors such as overlap of confidence intervals, and whether heterogeneity was in the magnitude or in the direction of the effect. Where levels of clinical and statistical heterogeneity permitted, the data were pooled in a meta-analysis using Review Manager 5.1 software (The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark) with a random-effects model. Absolute risk differences were also calculated in order to determine the number needed to treat (NNTT). When insufficient data were available for meta-analyses, a narrative synthesis of the outcome across the included studies was presented. The expected rate of SSI is 1-10 per cent. If missing randomized participants were assumed to indicate treatment failure (they had developed an infection), the rate of SSI would be increased falsely in the intervention group. As included trials had either complete data or minimal missing data, which was balanced over the intervention and control groups, complete case analysis was done for all trials in the review, recognizing the issue of trials with missing data when determining attrition bias in the risk-of-bias assessment.
If there were three or four arms in a study, where two or three of the arms were clinically similar for the purposes of the review, they were combined to create a single pairwise comparison. Where they could not be combined, multiple arms were included in the same analysis, but total results were not calculated in these tables.
One study 16 assessed multiple wounds per patient; randomization was at the level of the patient but the unit of analysis was the wound. The present authors could not find a published standard value for an inter-cluster correlation (ICC) for this scenario, so explored potential situations with different values used for ICC, and performed a sensitivity analysis on the overall effect. If the ICC was 1⋅0, as opposed to no adjustment for clustering, the RR did not change by a substantial amount, so no further adjustment was made.
Sensitivity analysis was done to assess the impact of risk of bias on the overall effect.
Results
The results of the search are shown in a PRISMA flow diagram (Fig. 1) . The search identified 763 studies of potential relevance. After the first screening, 66 citations were considered potentially relevant. A total of ten RCTs and four quasi-randomized trials with 6466 participants met the inclusion criteria. Their study characteristics are shown in Table 1 16 -28 . Ten two-arm studies were included, two three-arm studies 16, 19 and two four-arm studies 18, 25 . In all of the three-and four-arm trials, the intervention groups were considered to be receiving separate interventions and so all relevant comparisons were included.
Six studies 16 4, 17, 18, 22, 23 ; there were no dirty procedures.
Eight trials compared topical antibiotics with no topical antibiotics, and six compared topical antibiotics with topical antiseptics. Three of these trials had multiple arms comparing topical antibiotics with both antiseptics and no treatment.
Risk of bias in included studies
In total, seven 16, 17, 19, 20, 23, 26 of the 14 included trials were deemed to be at high risk of bias.
There were no trials in which participants were excluded from the analysis in sufficient numbers to cause potential bias. The dropout rate was no greater than 15 per cent in any trial, and numbers of dropouts were balanced between intervention and control groups when group allocation was recorded.
Two studies 19, 22 reported pharmaceutical sponsorship from companies that supplied one or more of the study agents.
Effects of interventions: prevention of surgical-site infection
Of the 14 trials included in the review, only 11 reported SSI as an outcome. In one of these trials 26 , the data for SSI were not extractable. This study was not included in data pooling for this outcome.
Topical antibiotic versus no topical antibiotic
Eight trials (5427 participants) were pooled to compare the effects of topical antibiotics with no topical antibiotics on SSI (Fig. 2 ). There were fewer infections with topical antibiotics than without (RR 0⋅61, 95 per cent c.i. 0⋅42 to 0⋅87). There was an absolute risk difference of 20 fewer SSIs per 1000 patients, and the number needed to benefit (NNTB) with topical antibiotic in order to avoid one additional SSI was 50. Most of these eight studies were at low or unclear risk of bias, and the quality of the evidence for this outcome was moderate. There was moderate interstudy heterogeneity (I 2 = 44 per cent).
The effect estimate was robust to removal of studies at high risk of bias (RR 0⋅49, 0⋅35 to 0⋅67; 3026 participants, 5 studies; I 2 = 0 per cent).
Pooling of three trials (3012 participants) that provided data on the risk of allergic contact dermatitis showed no difference (RR 3⋅94, 0⋅46 to 34⋅00; very low-quality evidence) (Fig. S1, supporting information) .
There were no trials reporting anaphylaxis or patterns of antibiotic resistance.
Topical antibiotic versus topical antiseptic
In the pooling of five trials (1299 participants), topical antibiotics reduced the risk of SSI compared with topical antiseptics (RR 0⋅49, 95 per cent c.i. 0⋅30 to 0⋅80; moderate-quality evidence) (Fig. 3) . This difference reflected an absolute difference in risk of 43 fewer cases of SSI per 1000 people treated with topical antibiotics rather than antiseptics (95 per cent c.i. 17 to 59 fewer per 1000; NNTB 24). There was minor interstudy heterogeneity (I 2 = 12 per cent).
The overall effect was robust to removal of studies at high risk of bias (RR 0⋅39, 0⋅20 to 0⋅76; 908 participants, 3 studies), and heterogeneity was reduced (I 2 = 0 per cent).
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Caro et al. 17 Dire et al. 18 21 Kamath et al. 24 Khalighi et al. 25 A Mantel-Haenszel random-effects model was used for meta-analysis. Risk ratios are shown with 95 per cent confidence intervals. *Three of the four study arms are used here; the two antibiotic arms were combined and compared with the inert control arm. †There were two no-treatment arms in this three-arm study; this comparison is mupirocin versus combined petroleum and no ointment. ‡Two of the three study arms are used here: topical antibiotic versus no-treatment control. §Three of the four study arms are used here: neomycin versus combined non-adherent dressing and standard dressing A Mantel-Haenszel random-effects model was used for meta-analysis. Risk ratios are shown with 95 per cent confidence intervals. *There were two antibiotic arms (bacitracin and neomycin), an antiseptic arm (silver) and an inert vehicle control arm (petroleum) in this four-arm study; this comparison is the two combined antibiotic arms versus the antiseptic arm. †Two of the three study arms are used here: topical antibiotic experimental versus antiseptic control arm. ‡Two of the four study arms are used here: neomycin versus povidone-iodine ointment Pooling of two trials (541 participants) showed no clear difference in the risk of allergic contact dermatitis with topical antibiotics compared with antiseptics (RR 0⋅97, 0⋅52 to 1⋅82; very low-quality evidence) (Fig. S2, supporting  information) .
Discussion
This systematic review and meta-analysis found that topical antibiotics applied to surgical wounds healing by primary intention reduced the risk of SSI, whether compared with no antibiotic or no topical antiseptic (moderate-quality evidence). In clean (class 1) surgery, where the baseline infection rate is already low, the absolute risk reduction in SSI is probably smaller, and the case for use of topical antibiotics weaker.
It was not possible to draw conclusions regarding the effects of topical antibiotics on allergic contact dermatitis owing to lack of statistical power (small sample sizes). Any use of topical antibiotic needs to be tempered by consideration of side-effects such as allergic contact dermatitis, and the evidence for this outcome, while critical, was found to be of very low quality. There were no patterns of antibiotic resistance or anaphylaxis in any of the studies identified. Subgroup analysis was not possible owing to lack of sufficient study numbers.
Some studies 16, 25, 28 had very low baseline rates of infection of around 2 per cent; for all other trials baseline rates were 10-20 per cent. In several of the studies 19, 21, 27 this baseline infection rate was higher than is considered to be acceptable 29 , and this may limit the applicability of the evidence. The mean absolute risk reduction was 4⋅3 per cent when compared with antiseptics, and 2 per cent when compared with no treatment, but this result was heterogeneous in both comparisons and much lower in studies with low baseline infection rates. Two of the three studies with low baseline infection rates involved class 1 wounds. The baseline results in these studies and the results of the meta-analysis raise the question of whether prophylaxis is necessary in populations with clean class 1 wounds. The NNTT for an additional beneficial outcome was 24 in the antiseptic comparator group and 50 in the no-treatment comparator group, but again would be much higher in situations where the baseline infection rate was low.
RCTs need to be adequately powered so that they are able to detect treatment effects of a specified size, should they exist. As the incidence of SSI is often low, an adequate number of patients need to be recruited to detect a clinically significant difference. Only three of the trials reported sample size calculations. One study 16 was underpowered because the baseline incidence of SSI was lower than that expected when the sample size was calculated. Some authors inappropriately reported topical antibiotics to be ineffective, rather than acknowledging that their study was underpowered.
In the existing published literature there was one editorial 30 , two literature reviews 31, 32 and three systematic reviews 33 -35 that, in all but one case, concluded that there was little evidence for the efficacy of topical antibiotics to prevent SSI, particularly after dermatological surgery. One study 35 pooled data from four studies comparing topical antibiotics with petroleum/paraffin for dermatological procedures, and favoured topical antibiotics (pooled odds ratio 0⋅71, 95 per cent c.i. 0⋅42 to 0⋅19). Guidelines 2,14 recommend that antibiotic prophylaxis, not limited to topical antibiotics, is not required for clean minor surgical procedures. National Institute for Health and Care Excellence (NICE) guidelines also state: 'do not use topical antibiotics in wounds healing by primary intention to reduce the risk of surgical site infection'
2 . The present review has contributed additional evidence, although practice must be guided by clinical judgement of risks and benefits.
